Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (402)

Latest Posts

About This Stock More About This Stock
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EDT
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EDT
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read
Biotech Avoids Tech Wreck Of June 9
Article By: Rod Raynovich
Monday, June 12, 2017 1:48 AM EDT
A big part of 2017 investing strategy will be picking the right sector. Healthcare appears to offer modest returns with a dividend play.
In this article: BAC, BMY, JNJ, MRK, PFE, IBB, AAPL, AMZN, GILD, NFLX, NVDA, TSLA, SMH, XBI, XLE, XLF, XLV, FB, ABBV, GOOGL, BLUE
Read
Gilead HIV Success Seen As Bulwark Against Patent Loss, Competition
Article By: The Fly
Tuesday, May 30, 2017 7:29 PM EDT
Gilead announced Tuesday that its latest HIV treatment candidate met its primary goal in four late-stage studies, showing "non-inferiority" against existing regimens, including a competitor from GlaxoSmithKline.
In this article: GSK, GILD
Read
Inovio Pharmaceuticals Surges Higher On Positive HIV Vaccine Results
Article By: Terry Chrisomalis
Saturday, May 27, 2017 12:00 PM EDT
Recently Inovio Pharmaceuticals (INO) announced positive results for an early stage HIV vaccine study. The vaccine produced one of the best immune responses seen to date in a human HIV clinical trial.
In this article: GILD Also: INO
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments